PTCY vs ATG in adjusted Cox models for PFS, GRFS, NRM, relapse, and grade 2 to 4 GVHD
| Outcome . | No. . | Events . | HR (95% CI) . | P value . |
|---|---|---|---|---|
| OS | ||||
| PTCY | 166 | 65 | ||
| ATG | 597 | 301 | 1.32 (1-1.74) | .05 |
| PFS | ||||
| PTCY | 165 | 75 | ||
| ATG | 595 | 328 | 1.33 (1.03-1.73) | .03 |
| GRFS | ||||
| PTCY | 162 | 102 | ||
| ATG | 580 | 392 | 1.24 (0.99-1.56) | .06 |
| NRM | ||||
| PTCY | 165 | 40 | ||
| ATG | 595 | 184 | 1.39 (0.97-2.01) | .07 |
| Relapse/progression | ||||
| PTCY | 165 | 35 | ||
| ATG | 595 | 144 | 1.29 (0.88-1.88) | .2 |
| aGVHD grade 2-4 | ||||
| PTCY | 164 | 41 | ||
| ATG | 575 | 197 | 1.61 (1.12-2.33) | .01 |
| cGVHD | ||||
| PTCY | 155 | 56 | ||
| ATG | 578 | 224 | 1.06 (0.77-1.47) | .7 |
| Outcome . | No. . | Events . | HR (95% CI) . | P value . |
|---|---|---|---|---|
| OS | ||||
| PTCY | 166 | 65 | ||
| ATG | 597 | 301 | 1.32 (1-1.74) | .05 |
| PFS | ||||
| PTCY | 165 | 75 | ||
| ATG | 595 | 328 | 1.33 (1.03-1.73) | .03 |
| GRFS | ||||
| PTCY | 162 | 102 | ||
| ATG | 580 | 392 | 1.24 (0.99-1.56) | .06 |
| NRM | ||||
| PTCY | 165 | 40 | ||
| ATG | 595 | 184 | 1.39 (0.97-2.01) | .07 |
| Relapse/progression | ||||
| PTCY | 165 | 35 | ||
| ATG | 595 | 144 | 1.29 (0.88-1.88) | .2 |
| aGVHD grade 2-4 | ||||
| PTCY | 164 | 41 | ||
| ATG | 575 | 197 | 1.61 (1.12-2.33) | .01 |
| cGVHD | ||||
| PTCY | 155 | 56 | ||
| ATG | 578 | 224 | 1.06 (0.77-1.47) | .7 |
Effect estimates are given with 95% CI and corresponding P values were calculated using the Wald test.